glp-1 drugs chemically different clinically similar The challenge of developing oral alternatives to Ozempic, Wegovy and Mounjaro GLP-1 Drug Comparison in Diabetes
Description
For states like Mississippi, West Virginia, and Arkansas, annual GLP-1 costs at commonly prescribed injectable prices can still represent more than 12% of median per capita income, roughly double the national average
In addition, BCBSM will change prior authorization requirements in this space on Saxenda, Wegovy and Zepbound beginning Aug
doi: 10.2337/diab.44.9.1126 [DOI] [PubMed] [Google Scholar] 54
I already collaborate with patients other providers about their metabolic health
doi: 10.2147/nss.S127475 23 BensonSArckPCTanSHahnSMannKRifaieNet al
